NationalStockNumber.INFO
Worldwide distributor of NSN parts and consumables located in the USA.
Worldwide distributor of NSN parts and consumables located in the USA.
An isomeric mixture in which the ortho isomer has been reduced to a . Excludes tri-o-cresyl phosphate, reagent.
Send us a request for quote using the form below. Our team will contact you with an up to date pricing and availability quote ASAP.
Phosphates, nesoi (excluding triammonium & trisodium)
Phosphates, n.E.S.
Chemicals-inorganic
Y - Indicates information is in the hazardous materials information resource system (hmirs).
PMICA - Item does not contain precious metal.
CRITL- The item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application.
004420 - Acid phospho-cresylic steel drums
635 - Chemicals, other than drugs or sundries
9 - Other or no special handling required (sh)
A - Shipment is not a consolidation and does not exceed 84 inches in any dimension.
C - Chemical corps items and all other chemicals not covered in other classificatons. note: when an item has a chemical proper shipp
Q - 70.0
Z - No special type of cargo code applicable
Questions & Answers: |
|
| What are the historical prices recorded for this stock number? | |
| Historical data shows pricing from $2,993.43 to $4,989.04.. | |
| Does NSN 6810-00-281-7478 have a shelf life? | |
| No. There is no shelf life applicable for this NSN. | |
| What NATO entities are users of this NSN? | |
| Department Of The Air Force, Department Of The Navy, Brazil, Spain, Malaysia, New Zealand, and Greece | |
| What is the NIIN of NSN 6810-00-281-7478? | |
| 002817478 or 00-281-7478 | |
| Does NSN 6810-00-281-7478 require demilitarization? | |
| Yes - ITAR Controlled | |
| What is the most recent solicitation for NSN 6810-00-281-7478? | |
| No solicitations for this NSN. | |
| When was this national stock number assigned to the federal catalog? | |
| Jan 01, 1963 | |
Effects of overexposure: ingestion may produce symptoms of non-specific
irrit.Of stomach tract,nausea,vomiting,cramps,diarhea
First aid: first aid: ingestion- give large amts of water or warm salty
water to induce vomiting. Eye contact: immediately flush eyes
w/large amts of running h*2o for 15 min. Skin contact: flush areas
with h*2o.I nhalation: remove from cont. Atmosphere.See doctor.
Hcc: n1
boiling pt: b.P. Text: 500f-527f
vapor density: ---
spec gravity: 1.167
viscosity: 125 sus @100f
solubility in water: negligible
appearance and odor: liquid, clear, transparent, essentially no odor.
percent volatiles by volume: nil
Chemicals on contact.
Waste disposal methods: contact the specialty chemical div; stauffer
chemical company, for recommendations on the disposal of unused
material.
disclaimer (provided with this information by the compiling agencies):
this information is formulated for use by elements of the department
of defense. the united states of america in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.
Ingred name: tricresyl phosphate
cas: 1330-78-5
rtecs #: td0175000
fraction by wt: 5%max
acgih tlv: 0.1 mg/cum (est
Ld50 lc50 mixture: ld50 (oral rat) is 4640 mg/kg
routes of entry: inhalation: yes skin: yes ingestion: no
reports of carcinogenicity: ntp: no iarc: no osha: no
health hazards acute and chronic: swallowing of sufficient quantities of
this material or prolonged skin or inhalation exposure may cause
nerve damage. There may also be cholinesterase inhibition.
explanation of carcinogenicity: none of the chemicals in this product is
listed by iarc, ntp or osha as a carcinogen.
effects of overexposure: nerve damage: weakness, numbness and tingling
sensations of the hands and feet, cramps and loss of muscle
strength. Cholinesterase inhibition: salivation, sweating,
headache, nausea, muscle twitching, tremors, incoordination,
blurred vision, tears, abdominal cramps, diarrhea, and chest
discomfort.
medical cond aggravated by exposure: there are no data available which
address medical conditions that are generally recognized as being
aggravated by exposure to this product.
First aid: ingest: immediately give several glasses of water but do not
induce vomiting. See dr. Skin: flush all affected areas with plenty
of water for at least 15 min. If irritation persists, see dr. Eye:
flus h with plinty of running water for at least 15 min. See dr. If
irritation persists. Inhale: remove to fresh air. See dr. If
respiratory irritation occurs or if breathing becomes difficult.
Hcc: n1
boiling pt: b.P. Text: 500f,260c
vapor pres: 0.1 @311 f
spec gravity: 1.162
solubility in water: 0.2
appearance and odor: clear, transparent liquid, pale brown to colorless.
faint or no odor.
Stability indicator/materials to avoid: yes
none
stability condition to avoid: none
hazardous decomposition products: under fire conditions - toxic
phosphorus oxides.
Waste disposal methods: dispose of in accordance with all applicable
federal, state and local laws and regulations.
disclaimer (provided with this information by the compiling agencies):
this information is formulated for use by elements of the department
of defense. the united states of america in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.
Ingred name: tricresylphosphate
cas: 1330-78-5
rtecs #: td0175000
Routes of entry: inhalation: yes skin: yes ingestion: no
reports of carcinogenicity: ntp: no iarc: no osha: no
health hazards acute and chronic: the neurotoxic ortho isomer comprises
less than 1% of the technical grade tritolyl phosphate. The meta
and para isomers are practically nontoxic and have not been
reported to cause nervous system inju ry.
explanation of carcinogenicity: none of the ingredients in this product
is listed by ntp, iarc or osha as a carcinogen.
effects of overexposure: eyes: transient irritation. Skin: harmful if
absorbed through skin. Inhalation: harmful if inhaled.
medical cond aggravated by exposure: individuals with a history of skin
and respiratory disorders may be at increased risk from exposure.
First aid: eyes: flush with plenty of water for at least 15 minutes. If
irritation persists, see doctor. Skin: wash with plenty of water
while removing contaminated clothing and shoes. If irritation
persists, se e doctor. Inhalation: remove victim to fresh air.
treat symptomatically. See doctor. Ingestion: do not induce vomit.
see doctor immediately.
Hcc: t6
boiling pt: b.P. Text: 770f,410c
vapor pres: negligible
vapor density: >1
spec gravity: 1.16
solubility in water: negligible
appearance and odor: colorless to pale yellow liquid.
percent volatiles by volume: 100
Stability indicator/materials to avoid: yes
strong oxidizing agents
stability condition to avoid: high heat, open flames.
hazardous decomposition products: carbon monoxide, carbon dioxide,
oxides of phosphorus.
Waste disposal methods: contact your local environmental officer.
dispose of in accordance with all federal, state and local
regulations. Manufacturer recommends incineration or contract with
licensed waste disposal agency.
disclaimer (provided with this information by the compiling agencies):
this information is formulated for use by elements of the department
of defense. the united states of america in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.
Ingred name: tricresylphosphate
cas: 1330-78-5
rtecs #: td0175000
fraction by wt: 100%
other rec limits: none specified
ingred name: the ortho isomer which comprises
tlv and pel of 0.1 mg/m3.
rtecs #: 9999999zz
other rec limits: none specified
Ld50 lc50 mixture: ld50 (oral rat) is 4640 mg/kg
routes of entry: inhalation: yes skin: yes ingestion: no
reports of carcinogenicity: ntp: no iarc: no osha: no
health hazards acute and chronic: swallowing of sufficient quantities of
this material or prolonged skin or inhalation exposure may cause
nerve damage. There may also be cholinesterase inhibition.
explanation of carcinogenicity: none of the chemicals in this product is
listed by iarc, ntp or osha as a carcinogen.
effects of overexposure: nerve damage: weakness, numbness and tingling
sensations of the hands and feet, cramps and loss of muscle
strength. Cholinesterase inhibition: salivation, sweating,
headache, nausea, muscle twitching, tremors, incoordination,
blurred vision, tears, abdominal cramps, diarrhea, and chest
discomfort.
medical cond aggravated by exposure: there are no data available which
address medical conditions that are generally recognized as being
aggravated by exposure to this product.
First aid: ingest: immediately give several glasses of water but do not
induce vomiting. See dr. Skin: flush all affected areas with plenty
of water for at least 15 min. If irritation persists, see dr. Eye:
flus h with plinty of running water for at least 15 min. See dr. If
irritation persists. Inhale: remove to fresh air. See dr. If
respiratory irritation occurs or if breathing becomes difficult.
Hcc: n1
boiling pt: b.P. Text: 500f,260c
vapor pres: 0.1
spec gravity: 1.167
solubility in water: 0.2%
appearance and odor: clear, transparent liquid, pale brown to colorless.
faint or no odor.
Stability indicator/materials to avoid: yes
none
stability condition to avoid: none
hazardous decomposition products: under fire conditions - toxic
phosphorus oxides.
Waste disposal methods: dispose of in accordance with all applicable
federal, state and local laws and regulations.
disclaimer (provided with this information by the compiling agencies):
this information is formulated for use by elements of the department
of defense. the united states of america in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.
Ingred name: tricresylphosphate
cas: 1330-78-5
rtecs #: td0175000
other rec limits: none specified